Clinical Trial Update: Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of icotinib for advanced non-small cell lung cancer in patients with hepatic insufficiency is ongoing. The trial status is currently un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN